RESUMEN
The fine specificity of the Ro and La proteins has been studied by several techniques. In general, there is agreement in a qualitative sense that autoantibodies bind multiple epitopes. For some specific antibody binding, different studies agree quantitatively, for instance, the binding of the carboxyl terminus of 60-kd Ro as described by 2 studies using different techniques and the presence of an epitope within the leucine zipper of 52-kd Ro. In addition, there is general agreement about the location of a prominent epitope at the RRM motif region of the La molecule. On the other hand, the many specific epitope regions of the molecules differ among these studies. These discrepancies are likely the result of using different techniques, sera, and peptide constructs as well as a result of inherent advantages and disadvantages in the individual approaches. Several theories concerning the origin of not only the antibodies, but also the diseases themselves, have been generated from studies of the fine specificity of antibody binding. These include a theory of a primordial foreign antigen for anti-Ro autoimmunity, molecular mimicry with regard to La and CCHB, as well as the association of anti-Ro with HLA. These remain unproven, but are of continuing interest. An explanation for the association of anti-60-kd Ro and anti-52-kd Ro in the sera of patients has sprung from evaluating antibody binding. Data demonstrating multiple epitopes are part of a large body of evidence that strongly suggests an antigen-driven immune response. This means that the autoantigens are directly implicated in initiating and sustaining autoimmunity in their associated diseases. A number of studies have investigated the possibility of differences in the immune response to these antigens in SS and SLE sera. While several differences have been reported, none have been reproduced in a second cohort of patients. Furthermore, none of the reported differences may be sufficiently robust for clinical purposes, such as distinguishing between SS with systemic features and mild SLE, although some might be promising. For instance, in at least 3 groups of SLE patients, no binding of residues spanning amino acids 21-41 of 60-kd Ro has been found. Meanwhile, 1 of those studies found that 41% of sera from patients with primary SS bound the 60-kd Ro peptide 21-41. Perhaps future studies will elaborate a clinical role of such a difference among SS and SLE patients. Study of the epitopes of these autoantigens has, in part, led to a new animal model of anti-Ro and anti-La. Non-autoimmune-prone animals are immunized with proteins or peptides that make up the Ro/La RNP. Such animals develop an autoimmune response to the entire particle, not just the immunogen. This response has been hypothesized to arise from autoreactive B cells. In another, older animal model of disease, the MRL-lpr/lpr mouse, B cells have recently been shown to be required for the generation of abnormal, autoreactive T cells. Thus, there are now powerful data indicating that B cells that produce autoantibodies are directly involved in the pathogenesis of disease above and beyond the formation of immune complexes. Given that the autoreactive B cell is potentially critical to the underlying pathogenesis of disease, then studying these cells will be crucial to further understanding the origin of diseases associated with Ro and La autoimmunity. Hopefully, an increased understanding will eventually lead to improved treatment of patients. Progress in the area of treatment will almost surely be incremental, and studies of the fine specificity of autoantibody binding will be a part of the body of basic knowledge contributing to ultimate advancement. In the future, the animal models will need to be examined with regard to immunology and immunochemistry as well as genetics. The development of these autoantibodies has not been studied extensively because upon presentation to medical care, virtually all patients have a full-
Asunto(s)
Especificidad de Anticuerpos/inmunología , Autoantígenos/inmunología , Autoinmunidad/inmunología , ARN Citoplasmático Pequeño , Ribonucleoproteínas/inmunología , Animales , Sitios de Unión de Anticuerpos/inmunología , Modelos Animales de Enfermedad , Humanos , Lupus Eritematoso Sistémico/inmunología , Ratones , Síndrome de Sjögren/inmunología , Antígeno SS-BAsunto(s)
Autoanticuerpos/sangre , Bloqueo Cardíaco/congénito , Bloqueo Cardíaco/inmunología , Intercambio Materno-Fetal/inmunología , Complicaciones del Embarazo/inmunología , Adulto , Anticuerpos Antinucleares/sangre , Antígenos Virales/sangre , Autoantígenos/inmunología , Femenino , Humanos , Embarazo , Retroviridae/inmunología , Ribonucleoproteínas/inmunología , Antígeno SS-BRESUMEN
A single dose of pasteurized Mycobacterium bovis administered intravenously to prediabetic non-obese diabetic (NOD) mice prevented the onset of type 1 diabetes but precipitated a systemic 'autoimmune rheumatic disease' (ARD) similar to systemic lupus erythematosus. This syndrome was characterized by haemolytic anaemia, anti-dsDNA and anti-Smith antigen (Sm) antinuclear autoantibodies, increased severity of sialadenitis and glomerular immune complex deposition. Here, we examine the specificity of the autoantibody responses in M. bovis-treated NOD mice. Large amounts of antibody were detected to the Sm/ribonucleoprotein (RNP) complex, of which the 28 000 MW polypeptide appeared to be immunodominant. The IgG subclass involved in the anti-Sm response was primarily IgG2a. Antibodies against dsDNA were also detected, but the subclass of this response was mixed, with IgG2a and IgG2b being present in equal amounts. Together, these findings argue against a role for immune deviation towards T helper type 2 (Th2) responses in pathogenesis of the disease. The anti-dsDNA and anti-Sm reactivities were not mediated by polyreactive antibodies since neither antigen could cross-compete plasma antibody binding to the other in competitive enzyme-linked immunosorbent assay. The role of polyclonal B-cell activation was examined by measuring total gamma-globulin as well as IgG reactive with other nuclear antigens including Ro60, Ro52 and La, which although not a major component of the autoantibody responses in these mice, did show small but significant increases following immunization with M. bovis. Thus polyclonal stimulation, while likely to be occurring, was not directly responsible for production of anti-Sm antibodies.
Asunto(s)
Linfocitos B/inmunología , Vacuna BCG/efectos adversos , Modelos Animales de Enfermedad , Lupus Eritematoso Sistémico/inmunología , Ratones Endogámicos NOD , Ribonucleoproteínas Nucleares Pequeñas , Animales , Anticuerpos Antinucleares/análisis , Autoanticuerpos/análisis , Autoantígenos/inmunología , Diabetes Mellitus Tipo 1/inmunología , Diabetes Mellitus Tipo 1/prevención & control , Electroforesis en Gel de Agar , Ensayo de Inmunoadsorción Enzimática/métodos , Técnica del Anticuerpo Fluorescente , Immunoblotting/métodos , Inmunoglobulina G/análisis , Lupus Eritematoso Sistémico/microbiología , Ratones , Células Th2/inmunología , Proteínas Nucleares snRNPRESUMEN
The onset of collagen-induced arthritis in DBA/1 mice is accompanied by a predominantly Th1 response, characterized by production of the proinflammatory cytokines IFN-gamma and TNF-alpha, and a predominance of IgG2a anti-collagen Abs. This study has primarily addressed the effects of continuous administration of exogenous IL-4, a Th2 cytokine, on collagen-induced arthritis in terms of time of onset, clinical symptoms, and histologic changes compared with those in untreated controls. The contributions of Th1 and Th2 cell responses were studied by examining anti-CII IgG subclasses, serum IgE levels, and cytokine production by synovial membrane and lymph node cell cultures. Continuous exposure to IL-4 for 28 days significantly delayed the onset of arthritis from 19 to 37 days and suppressed clinical symptoms. Arthritis occurred approximately 13 to 24 days after treatment ceased. Thereafter, the severity and duration of clinical symptoms were similar to those in control animals, although both joint damage and inflammation at the histologic and cellular levels were less severe than those in untreated controls. During IL-4 treatment, anti-collagen Ab levels were reduced (most significantly those of the IgG2a subclass), histology scores were lower, and the most striking effect was a 1000-fold decrease in TNF-alpha secretion by synovial cells. No significant differences in IgE levels were found between controls and IL-4-treated mice. These data suggest that the anti-inflammatory properties of IL-4 are mediated in part by down-regulation of Th1 responses rather than up-regulation of Th2 responses.
Asunto(s)
Artritis/prevención & control , Interleucina-4/farmacología , Animales , Artritis/etiología , Artritis/patología , Colágeno/inmunología , Citocinas/metabolismo , Sistemas de Liberación de Medicamentos , Inmunoglobulina E/análisis , Inmunoglobulina G/análisis , Interleucina-4/administración & dosificación , Interleucina-4/análisis , Ganglios Linfáticos/metabolismo , Masculino , Ratones , Ratones Endogámicos DBA , Membrana Sinovial/metabolismo , Factores de TiempoRESUMEN
The association of congenital heart block (CHB) with maternal autoantibodies to the Ro and La ribonucleoprotein antigens may be due to cross-reactions between maternal anti-La antibodies and fetal cardiac specific antigens. One of the major components of cardiac myocytes, laminin, is accessible for binding by maternal autoantibodies and we have previously reported cross-reactivity of mouse laminin with anti-La antibodies affinity purified from the sera of patients with primary Sjögren's syndrome. Affinity purified anti-La antibodies from ten women who had at some time given birth to a child with CHB were examined for cross-reactivity with human placental laminin, which shares structural similarities with cardiac laminin. All ten anti-La antibodies bound to the surface of cryosections of normal full term placental trophoblasts. Binding could be inhibited by pre-incubation of antibodies with either La or placental laminin. Eight anti-La antibodies also reacted with placental laminin by ELISA and La inhibited up to 82% of binding to laminin while laminin inhibited up to 85% of binding to La in a dose dependent manner. Eight anti-La antibodies also bound to the surface of fetal cardiac myocytes at 10.3 weeks of gestation and five showed lower levels of reactivity with the surface of fetal cardiac myocytes at 16.5 weeks of gestation. None showed any surface staining of normal adult heart. These data confirm the cross-reactivity of anti-La antibodies with laminin and may support a placental role in preventing the majority of potentially pathogenic antibodies from reaching the fetal circulation.
Asunto(s)
Bloqueo Cardíaco/congénito , Laminina/inmunología , Autoanticuerpos/inmunología , Autoanticuerpos/metabolismo , Autoantígenos/inmunología , Western Blotting , Reacciones Cruzadas , Ensayo de Inmunoadsorción Enzimática , Femenino , Feto/química , Corazón/embriología , Bloqueo Cardíaco/inmunología , Humanos , Inmunohistoquímica , Laminina/metabolismo , Intercambio Materno-Fetal/inmunología , Miocardio/química , Placenta/química , Embarazo , Unión Proteica/fisiología , Ribonucleoproteínas/inmunología , Antígeno SS-BRESUMEN
Endogenous retrovirus-3 (ERV-3) is an endogenous retrovirus encoding an open reading frame for an envelope protein expressed in placenta. In this study we also found high levels of expression in fetal heart, with peak expression occurring between 11 and 17 weeks of gestation. Antibodies to a peptide corresponding to a predicted epitope of ERV-3 were studied by ELISA in sera from 32 healthy women, 47 women during pregnancy, 19 post-partum, 34 with Sjogren's syndrome (SS), 28 with systemic lupus erythematosus (SLE) and 48 mothers of babies with congenital heart block (CHB). Elevated levels of antibodies to ERV-3 were found in normal pregnancy and in patients with SS or SLE. Compared with normal sera the highest levels occurred in mothers of CHB babies (P < 0.001). Antibodies from sera from three CHB mothers bound to recombinant transmembrane protein of ERV-3 on immunoblots, and to sections of fetal cardiac tissue and placenta. This study has shown evidence of autoimmunization to ERV-3 during pregnancy, with particularly high levels of antibodies in mothers of CHB babies. The expression of ERV-3 in fetal heart and the presence of antibodies in maternal sera suggest a possible role in the pathogenesis of CHB.
Asunto(s)
Anticuerpos Antivirales/análisis , Corazón Fetal/virología , Feto/virología , Bloqueo Cardíaco/congénito , Bloqueo Cardíaco/virología , Infecciones por Retroviridae/inmunología , Retroviridae/crecimiento & desarrollo , Retroviridae/inmunología , Adulto , Enfermedades del Tejido Conjuntivo/sangre , Enfermedades del Tejido Conjuntivo/inmunología , Enfermedades del Tejido Conjuntivo/virología , Electroforesis en Gel de Poliacrilamida , Ensayo de Inmunoadsorción Enzimática , Femenino , Técnica del Anticuerpo Fluorescente Directa , Bloqueo Cardíaco/sangre , Humanos , Immunoblotting , Inmunoglobulina G/análisis , Inmunoglobulina G/inmunología , Hibridación in Situ , Riñón/virología , Hígado/virología , Pulmón/virología , Lupus Eritematoso Sistémico/sangre , Lupus Eritematoso Sistémico/inmunología , Lupus Eritematoso Sistémico/virología , Embarazo , Proteínas Recombinantes/inmunología , Recombinación Genética , Retroviridae/genética , Síndrome de Sjögren/sangre , Síndrome de Sjögren/inmunología , Síndrome de Sjögren/virología , Piel/virología , Bazo/virología , Proteínas Virales/genética , Proteínas Virales/inmunologíaRESUMEN
Cross-reactions between maternally derived autoantibodies and fetal cardiac antigens have been postulated to play a role in the pathogenesis of congenital heart block (CHB). We have explored the cross-reactivity of autoantibodies to the small ribonuclear autoantigens, La/SS-B and Ro/SS-A, with laminin, the major component of cardiac sarcolemmal membrane using affinity-purified antibodies from patients with Sjögren's syndrome (SS). Anti-La antibodies purified from eight of 10 patients cross-reacted significantly with mouse laminin by ELISA. In contrast, purified antibodies to Ro52 from the same 10 patients showed little or no binding to laminin. Laminin inhibited up to 70% binding of anti-La antibodies to La antigen, and La inhibited up to 65% binding of anti-La antibodies to laminin. The cross-reaction was further examined on cryosections of 10 human fetal hearts aged from 8.7 to 14.9 weeks of gestation, two normal adult hearts, and one pathological adult heart with a diagnosis of dilated cardiomyopathy. Anti-Ro52 antibodies did not bind to the surface of cardiac cells. However, anti-La antibodies from seven of 10 patients tested bound to the surface of fetal myocytes from hearts aged 9.4 to 14.9 weeks of gestation, and also to the myocytes from the pathological adult heart but not to normal adult hearts. Preincubation with La antigen abolished the binding of anti-La antibodies to the surface of adult heart myocytes with dilated cardiomyopathy, and pre-incubation with mouse laminin could partially block this binding. These results suggest that molecular mimicry between laminin and La, but not Ro52, may act as a target for specific maternal autoantibodies, and contribute to the pathogenesis of CHB at a critical stage during fetal cardiac development.
Asunto(s)
Anticuerpos Antinucleares/inmunología , Bloqueo Cardíaco/congénito , Bloqueo Cardíaco/inmunología , Laminina/inmunología , Adulto , Anciano , Afinidad de Anticuerpos , Western Blotting , Células Cultivadas , Reacciones Cruzadas/inmunología , Electroforesis en Gel de Poliacrilamida , Ensayo de Inmunoadsorción Enzimática , Corazón Fetal/inmunología , Técnica del Anticuerpo Fluorescente , Humanos , Inmunidad Materno-Adquirida , Persona de Mediana Edad , Miocardio/inmunologíaRESUMEN
Non-obese diabetic (NOD) mice spontaneously develop organ-specific autoimmunity and are widely used as a model for diabetes. Aged NOD mice also exhibit some features of non-organ-specific autoimmune rheumatic disease such as anti-nuclear antibodies and late-onset haemolytic anaemia. Here, we report that a single dose of 2.6 x 10(7) heat-killed bacillus Calmette-Guérin (BCG) i.v. in 8-week-old NOD mice prevented diabetes but precipitated a syndrome similar to systemic lupus erythematosus (SLE). Treated mice developed haemolytic anaemia, anti-DNA and anti-Sm anti-nuclear autoantibodies and an increased severity of sialadenitis. Perivascular lymphocytic infiltration in the kidneys and glomerular immune complex deposition were also found. The action of BCG appeared to be mediated by an adjuvant-like activity as treated mice showed a substantial increase in reticuloendothelial cell function and enhanced antigen presentation capacity.
Asunto(s)
Enfermedades Autoinmunes/inmunología , Vacuna BCG/inmunología , Diabetes Mellitus Tipo 1/inmunología , Lupus Eritematoso Sistémico/inmunología , Anemia Hemolítica Autoinmune/inmunología , Animales , Anticuerpos Antinucleares/sangre , Enfermedades Autoinmunes/etiología , Femenino , Enfermedades Renales/inmunología , Lupus Eritematoso Sistémico/etiología , Masculino , Ratones , Ratones Endogámicos NOD , Ratones Endogámicos , Factores Sexuales , Sialadenitis/inmunología , Especificidad de la EspecieRESUMEN
Epitopes with linear sequences recognized by anti-La autoantibodies from seven mothers of children with congenital heart block were recently defined. Eight of these epitopes share sequence identity with three other proteins in addition to the original autoantigen, La. The three proteins are human cardiac myosin beta heavy chain, laminin B1 chain and the M6 protein of Streptococcus pyogenes. Affinity purified anti-La antibodies from a further three mothers bound to the La antigen and also to human cardiac myosin and mouse laminin. Affinity purified antibodies from three mothers of healthy children bound to the La antigen but showed minimal binding to either human cardiac myosin or mouse laminin. Cardiac myosin inhibited the binding of CHB-related anti-La antibodies to both La and myosin. These data support a role for maternal autoantibodies crossing the placenta and recognizing foetal cardiac antigens accessible at a critical developmental stage during gestation. We suggest that this would lead to complement fixation, inflammation and the subsequent pathology associated with congenital heart block.
Asunto(s)
Autoanticuerpos/inmunología , Proteínas de la Membrana Bacteriana Externa , Proteínas Portadoras , Bloqueo Cardíaco/etiología , Secuencia de Aminoácidos , Afinidad de Anticuerpos , Antígenos Bacterianos/inmunología , Autoantígenos/inmunología , Proteínas Bacterianas/inmunología , Western Blotting , Reacciones Cruzadas , Relación Dosis-Respuesta Inmunológica , Ensayo de Inmunoadsorción Enzimática , Epítopos/genética , Femenino , Bloqueo Cardíaco/congénito , Humanos , Laminina/inmunología , Intercambio Materno-Fetal , Datos de Secuencia Molecular , Miosinas/inmunología , Embarazo , Ribonucleoproteínas/inmunología , Homología de Secuencia , Síndrome de Sjögren/inmunología , Antígeno SS-BAsunto(s)
Autoanticuerpos/inmunología , Autoantígenos/inmunología , Enfermedades del Tejido Conjuntivo/inmunología , Epítopos/inmunología , Secuencia de Aminoácidos , Autoantígenos/química , Secuencia de Bases , Enfermedades del Tejido Conjuntivo/microbiología , Reacciones Cruzadas/inmunología , Epítopos/química , Humanos , Datos de Secuencia MolecularRESUMEN
The immune response to extrinsic and intrinsic antigens involves specific antigen receptors on T and B cells. The precise antigenic determinants, or epitopes, recognized by these receptors are discrete sequences within the native antigen. The ability to identify and manufacture key epitopes in the immune response has important implications for disease diagnosis and immunointervention. Consequently, increasingly sophisticated technologies are being applied to epitope mapping. This report from a recent workshop gives a balanced view of progress to date and the challenges ahead.
Asunto(s)
Epítopos , Mapeo Peptídico , Linfocitos B/inmunología , Conformación Proteica , Proteínas/inmunología , Linfocitos T/inmunologíaRESUMEN
Congenital complete heart block (CCHB) is a rare but potentially fatal disease of infants born to mothers with autoimmune disease where maternal autoantibodies to Ro (SS-A) are thought to cross the placenta and damage fetal cardiac tissue. We have adopted a novel approach to demonstrate the localization and specificity of maternal autoantibodies deposited in fetal heart. We raised an anti-idiotype against maternal anti-La antibodies, which reacted strongly with the surface immunoglobulin on the myocardial fibres from a CCHB heart but not a control fetal heart of the same age. Maternal immunoglobulin eluted from the CCHB heart reacted with La (SS-B) by ELISA. Using monoclonal and affinity-purified antibodies to La and affinity-purified anti-Ro antibodies, both antigens were identified on the surface of the fibres of the affected heart. Surface co-expression of immunoglobulin, complement and Class II antigen, consistent with a local immune response, was also found. This is the first definitive demonstration of Ro and La antigens and specific maternal anti-La antibody and idiotype on the surface of myocardial fibres in CCHB. It suggests that induction of Ro and La antigens on the surface of myocardial fibres during fetal development may be critical in the localization of the specific autoantibodies and subsequent evolution of congenital complete heart block.
Asunto(s)
Anticuerpos Antinucleares , Autoantígenos , Bloqueo Cardíaco/congénito , ARN Citoplasmático Pequeño , Enfermedades Autoinmunes/complicaciones , Enfermedades Autoinmunes/inmunología , Femenino , Corazón Fetal/inmunología , Bloqueo Cardíaco/etiología , Bloqueo Cardíaco/inmunología , Humanos , Idiotipos de Inmunoglobulinas , Recién Nacido , Masculino , Miocardio/inmunología , Embarazo , Complicaciones del Embarazo/inmunología , Ribonucleoproteínas/inmunología , Antígeno SS-BRESUMEN
To assess the response to Epstein-Barr virus (EBV) infection in patients with primary Sjögren's syndrome (SS), the frequency of detection of EBV DNA was studied in salivary gland biopsies and the antibody and idiotypic response to the virus was compared with healthy controls and infectious mononucleosis (IM). Viral DNA, detected by in-situ hybridization, was found in biopsies from two out of 12 patients with SS and six out of 10 controls. IgG, IgA and IgM antibodies to the virus, measured by ELISA using synthetic peptides (early antigen and EBNA-1) and a cloned fusion protein (EBNA-1), were normal in sera from 20 patients with SS, whereas infectious mononucleosis patients showed an increase in IgM antibodies to EBNA-1 and IgG antibodies to early antigen. One similarity between infectious mononucleosis and Sjögren's syndrome was a significant increase in the germline heavy chain idiotype G6 in both diseases, suggesting activation of similar B-cell subsets. It is possible that this is due to EBV, though the low frequency of EBV DNA in biopsies and the normal levels of EBV antibodies in SS does not lend any evidence that the virus itself is the causative agent.
Asunto(s)
Infecciones por Herpesviridae/complicaciones , Herpesvirus Humano 4/aislamiento & purificación , Síndrome de Sjögren/complicaciones , Anticuerpos Antivirales/análisis , Antígenos Virales , Artritis Reumatoide/complicaciones , Artritis Reumatoide/microbiología , ADN Viral/análisis , Infecciones por Herpesviridae/inmunología , Herpesvirus Humano 4/inmunología , Idiotipos de Inmunoglobulinas/análisis , Glándulas Salivales/análisis , Glándulas Salivales/microbiología , Síndrome de Sjögren/inmunología , Síndrome de Sjögren/microbiologíaRESUMEN
We investigated the possibility that autoantibodies are locally synthesized and secreted within salivary glands of patients with Sjögren's syndrome by measuring specific autoantibody as a proportion of the total immunoglobulin present both in serum and saliva. Of 25 patients studied, 21 showed salivary enrichment of IgA anti-La, in three cases IgA anti-La being detected in saliva when IgG anti-La was negative (by ELISA) in serum. Twenty-four showed enrichment of salivary rheumatoid factors and IgA and/or IgM carrying the 17-109 idiotype, a marker of kappa IIIb light chains. These data suggest that autoantibodies, especially of the IgA class, are synthesized primarily in salivary gland and that they can be detected in saliva before they become apparent in the peripheral circulation. The subsequent deposition of these antibodies within salivary glands may be a contributory factor to the pathogenesis of Sjögren's syndrome.
Asunto(s)
Autoanticuerpos/análisis , Glándulas Salivales/inmunología , Proteínas y Péptidos Salivales/análisis , Síndrome de Sjögren/inmunología , Anticuerpos/análisis , Autoanticuerpos/biosíntesis , Autoanticuerpos/clasificación , Humanos , Inmunoglobulina A Secretora/análisis , Idiotipos de Inmunoglobulinas/análisis , Saliva/inmunología , Glándulas Salivales/metabolismo , Síndrome de Sjögren/sangreRESUMEN
This study describes the distribution of isotypes and idiotypes of two autoantibody populations, anti-La and rheumatoid factor, which co-exist in both the sera and saliva of patients with primary Sjögren's syndrome. The two autoantibodies are distinguished not only by their antigenic specificity but also by the nature of their idiotypic markers. IgA anti-La antibodies bearing restricted idiotypes are specifically enriched in saliva compared to serum suggesting their local synthesis. In contrast, rheumatoid factors bear cross-reactive idiotypes and may arise as a direct consequence of the secondary immune response.
Asunto(s)
Anticuerpos/inmunología , Autoantígenos/inmunología , Idiotipos de Inmunoglobulinas/inmunología , Factor Reumatoide/inmunología , Ribonucleoproteínas , Autoanticuerpos/análisis , Técnica del Anticuerpo Fluorescente , Humanos , Idiotipos de Inmunoglobulinas/análisis , Isotipos de Inmunoglobulinas/análisis , Factor Reumatoide/análisis , Saliva/análisis , Glándulas Salivales/análisis , Síndrome de Sjögren/sangre , Síndrome de Sjögren/inmunología , Antígeno SS-BRESUMEN
Peripheral blood mononuclear cells from patients with Sjögren's Syndrome spontaneously secrete autoantibodies to the La antigen when cultured in vitro. This paper reports that specific IgG autoantibody production in vitro is suppressed by pre-treatment of CD8+ enriched T cells with rabbit polyclonal antibodies to idiotypes borne by circulating autologous anti-La antibodies. Treatment of this T cell subpopulation with anti-idiotypes specific for circulating anti-La antibodies from other patients or for anti-DNA antibodies was without effect on anti-La antibody production. Similarly anti-La anti-idiotypes had no effect on the production of autoantibodies to other ribonucleoprotein antigens such as nRNP/Sm. These data show that CD8+ T cells are the main targets for anti-idiotypic control in vitro. We suggest that the relative deficit of these cells, plus a surfeit of CD4+ T cells at the site of the pathological lesion within the salivary gland permits localized production of autoantibodies. Thus, dysregulation of the idiotypic network could contribute to the pathogenesis of Sjögren's Syndrome.